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Studies in young populations show a strikingly high
lifetime incidence of syncope. Two recent surveys of
the frequency of syncope in medical students dem-
onstrated that 20–25% of males and 40–50% of fe-
males reported to have experienced at least one such
episode [6, 14]. The majority of the syncope triggers
identiﬁed in these students involved stresses or con-
ditions that affect orthostatic blood pressure control.
Neurally mediated syncope was therefore likely a
cause of the symptoms in these young subjects. The
incidence peak of presumed neurally mediated syn-
cope around the age of 15 years and the much higher
incidence in young females is a consistent ﬁnding [4,
6, 7, 14]. A family history of presumed neurally
mediated syncope in the ﬁrst-degree relatives is often
present in young fainting subjects [14]. Compared to
the 30% incidence of presumed neurally mediated
syncope in young medical students, the prevalence of
epileptic seizures in a similar young age group is
much lower (less than 1%) and syncope resulting
from cardiac arrhythmias or structural heart disease,
i.e., cardiac syncope, is even less common [4].
Emotional stress or pain and orthostatic stress in
combination with symptoms and signs like sweating
and nausea are classical symptoms of vasovagal
fainting [18], but a classical presentation occurs in a
minority of the cases. In the other patients less well-
known stresses or conditions that affect orthostatic
blood pressure control are involved and triggers and
symptoms may vary between episodes in one patient
[4, 6]. Nevertheless, without abnormalities at physical
examination or on the electrocardiogram the diag-
nosis reﬂex syncope can safely be made [3].
Whenever malignant ventricular arrhythmias in the
young age group are documented, a careful workup is
mandatory and speciﬁc protocols should be followed.
At young age these investigations should also be di-
rected to relatively rare primary arrhythmia syn-
dromes, including catecholaminergic polymorphic
ventricular tachycardia (CPVT), the long QT syn-
dromes and Brugada syndrome. Indeed, in victims of
unexplained sudden cardiac death, screening of family
members revealed evidence for the presence of a pri-
mary electrical disease in a substantial number of
families [2, 17]. In the absence of any clear electro-
physiological markers for these diseases, pharmaco-
logicaltestscanbeusedtounmaskthesesyndromes[1,
9, 15]. In idiopathic’ VF patients the incremental
diagnostic value of the epinephrine and procainamide
tests have been elegantly demonstrated by Krahn et al.
[9]. In this study the additional diagnostic yield was
34%, ﬁve additional patients with CPVT and one
Brugada syndrome patient were diagnosed [9].
Importantly, it should be noted that procainamide is
not even the most potent drug in unmasking Brugada
syndrome [1].
The patient described by Donnelly et al. in this
issue of Clinical Autonomic Research [5] presenting
with ventricular ﬁbrillation (VF) should, despite the
Arthur A.M. Wilde
Wouter Wieling Vasovagal syncope or ventricular
fibrillation. Your diagnosis better
be accurate
Published online: 30 July 2007
A.A.M. Wilde (&)
Dept. of Cardiology
Academic Medical Centre
University of Amsterdam
Amsterdam, The Netherlands
E-Mail: a.a.wilde@amc.uva.nl
W. Wieling
Dept. of Internal Medicine
Academic Medical Centre
University of Amsterdam
Amsterdam, The Netherlands
EDITORIAL
Clin Auton Res (2007) 17:203–205
DOI 10.1007/s10286-007-0432-1
C
A
R
4
3
2clear history of vasovagal syncope, have undergone
this systematic workup. A normal transthoracic echo
is insufﬁcient to exclude discrete anatomical abnor-
malities (cardiomyopathies, among which arrhythm-
ogenic right ventricular cardiomyopathy) and
coronary anomalies (including coronary spasm) and
primary electrical diseases are not or hardly ad-
dressed. Hence, the diagnosis idiopathic’ VF cannot
be made. Actually, CPVT is well possible given the
(emotional) stress related events and the ventricular
ectopy during atrial ﬁbrillation with rapid ventricular
rate (ﬁgure 2 in the manuscript). Furthermore, in all
ECGs of this patient repolarization is abnormal. A
minimum requirement therefore would have been an
exercise test and, as stated above, additional phar-
macological tests reveal a signiﬁcant incremental
number of diagnoses and would have been useful in
this case [9]. In our view, none of the primary elec-
trical diseases are presently excluded. This is even
more important because two of the ﬁrst degree rela-
tives are symptomatic as well.
Inthepatientathand,arrhythmiasareonlycausally
excluded in the last two described syncopal episodes
(after ICD implant). In addition, it is also well con-
ceivable that the majority of her earlier (prior to ICD
implant) syncopal episodes were also related to an in-
crease in vagal tone (vasovagal syncope). Yet, at least
once a lethal arrhythmia was documented and it is
tempting to speculate that vagal stimuli might be
causally involved herein as well. Indeed, in Brugada
syndrome patients, acethylcholine has been shown to
increase the right precordial ST-segment amplitude
[13]andtherebypotentiallytheriskforlife-threatening
arrhythmias that are indeed, shown to be most pre-
valent in the early morning hours when vagal tone is
highest [12]. Vagally-induced idiopathic’ VF has been
demonstrated in patients with characteristics of Brug-
ada syndrome [8] and several case-reports have sug-
gested an association between Brugada syndrome and
vasovagal syncope [10]. Also in LQTS sudden changes
in autonomic tone might be causal to arrhythmias be-
cause sudden changes in heart rate, also bradycardia,
are pro-arrhythmic in various LQT syndromes [16].
CPVT is not related to increased vagal tone. These
considerations also warrant a careful review of the
patient with a diagnosis of vasovagal syncope after
history taking, and an abnormal ECG. Because vaso-
vagal syncope is as common a syndrome the chance of
ﬁnding it as a comorbid condition is almost 40% of
young patients with documented VF. Single episodes
that are typical for VVS, next to episodes indicative of
VF, can therefore never be used as an exclusion crite-
rion for VF.
In conclusion, in this patient, vasovagal syncope
and ventricular ﬁbrillation coincide. The pressing
questiontoaddressiswhetherthesetwoconditionsare
related or not. A thorough cardiological work-up fol-
lowing predeﬁned protocols is an absolute require-
ment to provide an adequate answer. In the interest of
the patient and her family, the VF episode also
necessitates active family screening including phar-
macological testing in the family members, particu-
larly in the two symptomatic sisters. Despite the fact
that vasovagal syncope is very common and has also
been reported to be familial [11, 14], this additional
testing is mandatory before they can be reassured.
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